(Q40869949)

24 September 2017

title

The effectiveness of the short- and long-term use of crystallized theophylline in asthmatic children (English)

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

24 June 2022

0 references

R. M. Katz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A344850

24 June 2022

G. S. Rachelefsky

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A344850

24 June 2022

S. Siegel

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A344850

24 June 2022

language of work or name

English

0 references

publication date

1 April 1978

1 reference

full work available at URL

24 September 2017

https://api.elsevier.com/content/article/PII:S0022347678803187?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

https://api.elsevier.com/content/article/PII:S0022347678803187?httpAccept=text/plain

24 June 2022

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

The Journal of Pediatrics

24 June 2022

published in

1 reference

24 September 2017

volume

92

1 reference

24 September 2017

issue

4

1 reference

24 September 2017

page(s)

663-667

1 reference

Evaluation of oral bronchodilator therapy in asthmatic children. Bronchodilators in asthmatic children.

24 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

A controlled study of cromolyn sodium sponsored by the Drug Committee of the American Academy of Allergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

CLINICAL AND LABORATORY EVALUATION OF AN ANTIASTHMATIC PREPARATION WITH PROLONGED ACTION

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

Influence of Formulation on Bioavailability Of Theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

Rational Intravenous Doses of Theophylline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

Ephedrine therapy in asthmatic children. Clinical tolerance and absence of side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

Theophylline toxicity due to impaired theophylline degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

Inhibition of theophylline clearance by troleandomycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3476%2878%2980318-7

An ultraviolet spectrophotometric method for the determination of theophylline and theobromine in blood and tissues

7 January 2021

3

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

Pharmacokinetics of theophylline in children with asthma

2 April 2023

6

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

A rapidly dissolving theophylline tablet

2 April 2023

8

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

Clinical trial of rapidly dissolving theophylline tablets

2 April 2023

10

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

Blood levels following oral administration of theophylline preparations

2 April 2023

15

1 reference

https://api.crossref.org/works/10.1016/S0022-3476(78)80318-7

2 April 2023

Identifiers

1 reference

24 September 2017

1 reference